IP Library Granted Patent US 10,047,040
Granted Patent B2
US 10,047,040 · App. 15/502,512 · Granted Aug 14, 2018

Sulfonylaminobenzamide compounds as anthelmintics

Inventors: Noelle Gauvry (Kembs, FR); Chouaib Tahtaoui (Rixheim, FR)
Assignee: Elanco Tiergesundheit AG
C07C311/08C07C311/14C07C311/21C07D209/08C07D213/56C07D213/61C07D213/84C07D215/06C07D231/12C07D231/56C07D237/26C07D239/26C07D239/30C07D249/08C07D263/50C07D275/03C07D277/30C07D277/46C07D277/54C07D277/56C07D277/60C07D277/64C07D285/135C07D295/155C07D309/06C07D317/66C07D333/24C07D333/28C07D333/78C07D487/04C07F5/025C07F7/0818C07C2601/02C07C2601/14C07C2602/08C07C2602/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,047,040
App. No.
15/502,512
Granted
Aug 14, 2018
Kind
B2
Abstract

The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.

Claims (65)

1. A compound of formula

or a salt or an enantiomer thereof, wherein

n is 1;

A is a phenyl radical which is substituted by chlorine, fluorine or CF 3 ;

R 2 is H or —S(O 2 )-T;

T is C 1 -C 6 -alkyl which is unsubstituted or substituted by halogen, trimethylsilyl, C 3 -C 6 -cycloalkyl, carboxyl or C 1 -C 4 -alkoxycarbonyl; C 3 -C 6 -cycloalkyl; C 6 -C 12 -bicarbocyclyl; phenyl which is unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl or C 1 -C 4 -alkoxy; a 5- or 6 membered heteroaromatic radical, which is further unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl or C 1 -C 4 -alkoxy; 5- or 6-membered heterocycloalkyl having from 1 to 3 same or different heteroatoms selected from the group consisting of N, O, S and S(O 2 ), which is further unsubstituted or substituted by C 1 -C 4 -alkyl, C 1 -C 2 -alkoxycarbonyl or benzyloxycarbonyl; a group

amino; or N-mono- or N,N-di-C 1 -C 4 -alkylamino;

R 3 is C 1 -C 4 -alkyl, unsubstituted or halogen-, C 1 -C 4 -alkyl- or C 1 -C 4 -haloalkyl-substituted phenyl, unsubstituted or halogen-, C 1 -C 4 -alkyl- or C 1 -C 4 -haloalkyl-substituted pyridyl, C 1 -C 4 -alkoxycarbonyl-methyl or morpholin-4-yl-carbonylmethyl;

R 0 is H or hydroxy; and

Y is

(i) phenyl or a phenylamino, which is substituted by one or more same or different radicals selected from the group consisting of halogen; C 1 -C 2 -alkyl; C 1 -C 3 -haloalkyl; C 1 -C 2 -alkoxy; C 1 -C 3 -haloalkoxy; C 1 -C 2 -haloalkylthio; SF 5 ; cyano; nitro; hydroxy; or methylsulfonylamino; or is

(ii) 5- or 6 membered heteroaryl or heteroarylamino, which is each further unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, C 2 -C 4 -alkanoyl, or phenyl or phenylsulfonyl which is each unsubstituted or substituted by halogen, cyano, nitro, methyl or methoxy; or is

(iii) benzoyl or 5- or 6 membered heteroarylcarbonyl, which is each further unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, C 2 -C 4 -alkanoyl or phenyl; or is

(iv) a C 6 -C 12 -bicarbocyclic radical; or is a

(v) a hetero-bicyclic ring radical comprising a total of 8 to 10 ring members, from which 1 to 5 members are same or different heteroatoms selected from the group consisting of B, N, O and S, and from which 0 to 2 members are a group —C(O)—, which bicyclic ring radical is further unsubstituted or substituted by halogen, cyano, hydroxyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl; or is

(vi) a radical —H 2 C—C(O)—NH—R 4 , wherein R 4 is C 1 -C 4 -haloalkyl, C 2 -C 3 -alkynyl or cyano-C 1 -C 4 -alkyl; or

R 0 and Y together with the N-atom to which they are attached, form a piperidinyl or piperazinyl radical which is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, unsubstituted or halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, amino- and/or C 1 -C 4 -alkoxy-substituted phenyl or benzoylamino, or unsubstituted or C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl- or halogen-substituted pyridyl or pyrimidinyl; subject to the proviso that

at least one of A and Y must not be a phenyl radical if T is CH 3 .

2. A compound according to claim 1 , wherein

A is phenyl which is mono-substituted by chlorine, fluorine or CF 3 ,

Y is phenyl which is substituted by 2 or 3 same or different radicals selected from halogen or CF 3 , and

T is C 2 -C 4 -alkyl, which is unsubstituted or substituted by halogen, cyclopropyl, cyclohexyl, trimethylsilyl, carboxy or C 1 -C 2 -alkoxycarbonyl; cyclopropyl or cyclohexyl; the radical of (+)- or (−)-camphor; phenyl which is unsubstituted or substituted by fluorine, chlorine, methyl, methoxy, CF 3 or nitro; or pyridyl, thienyl or pyrimidinyl; piperidinyl, piperazinyl, tetrahydropyranyl, morpholinyl, thiomorpholinyl or thiomorpholin-4-yl-1,1-dioxide, which is each unsubstituted or substituted by methyl.

3. A compound according to claim 1 of formula

wherein

A is phenyl which is substituted as defined in claim 1 ;

R 0 is H or hydroxyl; and

Y″ is

(i) 5- or 6 membered heteroaryl or heteroarylamino, which is each further unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkanoyl or phenyl or phenylsulfonyl which is each unsubstituted or substituted by halogen, cyano, nitro, methyl or methoxy; or is

(ii) benzoyl or 5- or 6 membered heteroarylcarbonyl, which is each further unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkanoyl or phenyl; or is

(iii) a C 6 -C 12 -bicarbocyclic radical; or is a

(iv) a hetero-bicyclic ring radical comprising a total of 8 to 10 ring members, from which 1 to 5 members are same or different heteroatoms selected from the group consisting of B, N, O and S, and from which 0 to 2 are a group —C(O)—, which bicyclic ring radical is further unsubstituted or substituted by halogen, cyano, hydroxyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl; or is

(v) a radical —H 2 C—C(O)—NH—R 4 , wherein R 4 is C 1 -C 4 -haloalkyl, C 2 -C 3 -alkynyl or cyano-C 1 -C 4 -alkyl; or

R 0 and Y together with the N-atom to which they are attached, form a piperidinyl or piperazinyl radical which is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, unsubstituted or halogen-, C 1 -C 4 -alkyl-, halo-C 1 -C 4 -alkyl-, amino- and/or C 1 -C 4 -alkoxy-substituted phenyl or benzoylamino, or unsubstituted or C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl- or halogen-substituted pyridyl or pyrimidinyl.

4. A compound according to claim 3 , wherein

A is phenyl which is mono-substituted by chlorine, fluorine or CF 3 ;

R 0 is H, and

Y″ is

(i) 2-, 3- or 4-pyridyl which is unsubstituted or substituted by halogen, C 1 -C 4 -alkyl or C 1 -C 2 -alkoxy; 2-thienyl which is unsubstituted or substituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxycarbonyl; 2-thiazolyl which is unsubstituted or substituted by halogen, cyano, nitro, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, C 1 -C 2 -alkoxycarbonyl, or phenyl or phenylsulfonyl which is in turn each unsubstituted or substituted by halogen, cyano, nitro or methyl; 5-isothiazoyl which is unsubstituted or substituted by halogen or methyl; 2-oxazolyl, which is unsubstituted or substituted by C 1 -C 2 -alkyl or C 1 -C 2 -haloalkyl; or 1,3,4-thiadiazol-5-yl, which is unsubstituted or substituted by C 1 -C 2 -alkyl or C 1 -C 2 -haloalkyl; 2-, 3- or 4-pyridylamino, which is unsubstituted or substituted by halogen, C 1 -C 4 -alkyl or C 1 -C 2 -alkoxy; or

(ii) benzoyl which is unsubstituted or substituted by halogen, or 2-, 3- or 4-pyridylcarbonyl which is unsubstituted or substituted by halogen or C 1 -C 4 -alkyl; or

(iii) a radical

a radical

or indanyl; or

(iv) benzothiazolyl, indolyl, quinolinyl, methylenedioxophenyl, benzooxaboronyl, triazolopyrimidinonyl or phthalhydrazidyl, which is each unsubstituted or substituted by halogen, C 1 -C 4 -alkyl, C 1 -C 2 -haloalkyl or hydroxy; or

(v) a radical —H 2 C—C(O)—NH—CH 2 —C≡CH, —H 2 C—C(O)—NH—CH 2 —CN or —H 2 C—C(O)—NH—CH 2 —CF 3 ;

or R 0 and Y together with the N-atom to which they are attached, form a piperidinyl or piperazinyl radical, which is substituted by methyl; methoxy; halogen-, amino-, methoxy- or trifluoromethyl-substituted phenyl or benzoylamino; or halogen-, trifluoromethyl- and/or cyclopropyl-substituted pyridyl or pyrimidinyl.

5. A composition for the control of parasites, which contains as an active ingredient at least one compound of formula (I) according to claim 1 , in addition to carriers and/or dispersants.

6. A method of controlling endoparasites, on warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of at least one compound of formula (I) according to claim 1 .

7. A compound of the formula:

wherein

(R) m is H or 4-Cl;

T is 4-CH 3 -phenyl, phenyl, 2-NO 2 -4-CF 3 -phenyl, 3-Cl-4-F-phenyl, 2-CF 3 -4-F-phenyl, 4-CF 3 -phenyl, 3,4-dimethoxyphenyl, 4-nitrophenyl, 4-chlorophenyl, 3,5-di-Cl-phenyl, 4-methoxyphenyl, 2-chloro-phenyl, 3-chloro-phenyl, 3-pyridyl, 3-methoxyphenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl, 2-methoxyphenyl, 2,4-dichlorophenyl, 2-NO 2 -4-OCH 3 -phenyl, 2,4-dimethoxyphenyl, ethyl, —CH 2 CF 3 , —CH 2 CH 2 CF 3 , n-propyl, n-butyl, iso-butyl, —CH 2 CH 2 Si(CH 3 ) 3 , cyclopropyl, cyclohexyl, 1-(benzyloxycarbonyl)-piperazin-4-yl, isopropyl, cyclohexylmethyl, (1R)-(−-campher, —CH 2 C(O)OC 2 H 5 , —CH 2 C(O)OCH 3 , —CH 2 C(O)OH, (1S)-(+)-campher, tetrahydro-2H-pyran-4-yl, —N(CH 3 ) 2 , 1-methylpiperazin-4-yl, —CH 2 —Cl,

and

R 2 is H or —SO 2 CH 2 Cl.

8. A compound according to claim 7 , wherein (R) m is 4-Cl and R 2 is H.

9. A compound according to claim 7 , having the formula:

10. A composition for the control of parasites, which contains as an active ingredient the compound according to claim 7 , in addition to carriers and/or dispersants.

11. A method of controlling endoparasites, on warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of the compound according to claim 7 .

12. A compound of the formula:

wherein

R 0 is H or hydroxy; and

Y is

or R 0 and Y together with the N-atom to which they are attached, form

13. A compound according to claim 12 , wherein R 0 is H.

14. A composition for the control of parasites, which contains as an active ingredient the compound according to claim 12 , in addition to carriers and/or dispersants.

15. A method of controlling endoparasites, on warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of the compound according to claim 12 .

Assignments (4)
CHANGE OF NAME Recorded Aug 23, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043363/0007 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2017
From: NOVARTIS ANIMAL HEALTH, INC.
To: NOVARTIS AG
Reel/Frame 041199/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2017
From: GAUVRY, NOELLE; TAHTAOUI, CHOUAIB
To: NOVARTIS ANIMAL HEALTH, INC.
Reel/Frame 041654/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2017
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 041654/0415 →
Priority Claims (1)
EP 14182960 · Aug 29, 2014 · regional
Continuity (1)
Related Publication 20170226053A1 · Aug 10, 2017